most effective glp-1 drug Understanding medications List of approved and pending
Description
Purinergic Signal
"Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide in Head-to-Head Phase III Trial for Type 2 Diabetes" (Press release)
[DOI] [PubMed] [Google Scholar] 92.Fala L
Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
To assess heterogeneity, Chi-square and I 2 statistics were utilized, with significant heterogeneity defined as a p -value below 0.1 and an I 2 exceeding 50%
Tirzepatide, as a newer compound, has even longer patent protection
